Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su, Lanying Du, Shibo Jiang
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 211-219
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. 1107-1119
Open Access | Times Cited: 420
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines
Kellie D. Nance, Jordan L. Meier
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 748-756
Open Access | Times Cited: 322
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Qianqian Zhang, Rong Xiang, Shanshan Huo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 300
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao, Shan Zhao, Junxian Ou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 212
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study
Jian Wu, Quanman Li, Clifford Silver Tarimo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 118
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Qian He, Qunying Mao, Jialu Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
Anastasia Gangaev, Steven L. C. Ketelaars, Olga I. Isaeva, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
Francisco Tsz Tsun Lai, Lei Huang, Celine Sze Ling Chui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 76
Circular RNA vaccine in disease prevention and treatment
Dun Niu, Yaran Wu, Jiqin Lian
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Neutralizing antibodies for the treatment of COVID-19
Shibo Jiang, Xiujuan Zhang, Yang Yang, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1134-1139
Open Access | Times Cited: 112
The importance of Social Norms against Strategic Effects: The case of Covid-19 vaccine uptake
Marina Agranov, Matt Elliott, Pietro Ortoleva
Economics Letters (2021) Vol. 206, pp. 109979-109979
Open Access | Times Cited: 99
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
Yaling Wang, Yuping Xie, Jia Luo, et al.
Nano Today (2021) Vol. 38, pp. 101139-101139
Open Access | Times Cited: 81
A Membrane‐Targeting Photosensitizer with Aggregation‐Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses
Mingyu Wu, Meijia Gu, Jong‐Kai Leung, et al.
Small (2021) Vol. 17, Iss. 30
Open Access | Times Cited: 75
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
Qingrui Huang, Kai Ji, Siyu Tian, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 74
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
Yangtao Wu, Xiaofen Huang, Lunzhi Yuan, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 606
Open Access | Times Cited: 74
COVID-19 mRNA vaccines
Qingrui Huang, Jiawei Zeng, Jinghua Yan
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 2, pp. 107-114
Open Access | Times Cited: 72
Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19
Juan Du, Lirong Wei, Guoli Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 63
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, et al.
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 757-767
Open Access | Times Cited: 61
Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment
Calistus N. Ngonghala, Hémaho B. Taboe, Salman Safdar, et al.
Applied Mathematical Modelling (2022) Vol. 114, pp. 447-465
Open Access | Times Cited: 42
Economic evaluation of COVID-19 vaccination: A systematic review
Auliasari Utami, Farida Rendrayani, Qisty A Khoiry, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top